As of March 23, 2026, Indivior Pharmaceuticals's top three insider holders are Ryan Preblick (Chief Financial Officer, 317.29K shares), Christian Heidbreder (Chief Scientific Officer, 246.51K shares), Patrick A Barry (Chief Commercial Officer, 31.38K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Ryan Preblick | Chief Financial Officer | 320,751 | 0 | 17 Mar, 2026 |
| Daniel A Ninivaggi | 20,645 | 0 | 28 Jan, 2026 | |
| Mark Stejbach | 20,569 | 0 | 28 Jan, 2026 | |
| David E. Wheadon | 20,350 | 0 | 28 Jan, 2026 | |
| Juliet Thompson | 7,572 | 0 | 28 Jan, 2026 | |
| Barbara Ryan | 5,724 | 0 | 13 Mar, 2026 | |
| Stuart A Kingsley | 5,582 | 0 | 11 Mar, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Mar, 2026 | Ryan Preblick | Common Stock | A | 6,302 | - | 323,594 | D | M |
| 14 Mar, 2026 | Ryan Preblick | Common Stock | D | 2,843 | $31.11 | 320,751 | D | F |
| 14 Mar, 2026 | Ryan Preblick | Restricted Stock Units | D | 6,302 | - | 0 | D | M |
| 13 Mar, 2026 | Barbara Ryan | Common Stock | A | 8 | $31.09 | 5,724 | D | P |
| 06 Mar, 2026 | Stuart A Kingsley | Common Stock | A | 940 | $31.87 | 5,582 | D | P |
| 09 Mar, 2026 | Barbara Ryan | Common Stock | A | 31 | $32.56 | 5,716 | D | P |
| 03 Mar, 2026 | Ryan Preblick | Common Stock | D | 87,597 | $31.98 | 230,343 | D | F |
| 03 Mar, 2026 | Ryan Preblick | Common Stock | A | 86,949 | - | 317,292 | D | M |
| 03 Mar, 2026 | Ryan Preblick | Performance Stock Units | D | 113,510 | - | 0 | D | M |
| 10 Feb, 2026 | Ryan Preblick | Common Stock | A | 37,358 | $0.00 | 317,940 | D | A |
| 09 Feb, 2026 | Ryan Preblick | Performance Stock Units | A | 113,510 | $0.00 | 113,510 | D | A |
| 26 Jan, 2026 | David E. Wheadon | Common Stock | A | 5,955 | $0.00 | 20,350 | D | A |
| 26 Jan, 2026 | Daniel A Ninivaggi | Common Stock | A | 3,722 | $0.00 | 20,645 | D | A |
| 26 Jan, 2026 | Stuart A Kingsley | Common Stock | A | 3,722 | $0.00 | 4,642 | D | A |
| 26 Jan, 2026 | Mark Stejbach | Common Stock | A | 3,722 | $0.00 | 20,569 | D | A |
| 26 Jan, 2026 | Juliet Thompson | Common Stock | A | 3,722 | $0.00 | 7,572 | D | A |
| 26 Jan, 2026 | Barbara Ryan | Common Stock | A | 3,722 | $0.00 | 5,685 | D | A |
| 05 Jan, 2026 | Daniel A Ninivaggi | Ordinary Shares | A | 775 | $35.39 | 16,923 | D | P |
| 05 Jan, 2026 | David E. Wheadon | Ordinary Shares | A | 1,771 | $35.39 | 14,395 | D | P |
| 05 Jan, 2026 | Mark Stejbach | Ordinary Shares | A | 775 | $35.39 | 16,847 | D | P |